What question did this study set out to answer?

To determine the molecular mechanism of cryptolepine by investigating its DNA-binding properties, topoisomerase II interaction, and cellular effects in B16 melanoma cells.

March 19, 1998Biochemistry

The DNA Intercalating Alkaloid Cryptolepine Interferes with Topoisomerase II and Inhibits Primarily DNA Synthesis in B16 Melanoma Cells

View Full Paper

Ask AI

Bookmark

Authors

KBKarine BonjeanUniversity of Liège MPM. C. De Pauw-GilletUniversity of Liège MDMarie Paule DefresneUniversidade Federal do Rio de Janeiro

Discussion

Member takes

Implication

In vitro study reveals cryptolepine intercalates DNA and blocks topoisomerase II in B16 melanoma cells, highlighting its promise for antitumor drug development.

Key Points

To determine the molecular mechanism of cryptolepine by investigating its DNA-binding properties, topoisomerase II interaction, and cellular effects in B16 melanoma cells.
Characterized DNA binding modes and sequence specificity using absorption, fluorescence, circular and linear dichroism, and DNase I footprinting.
Evaluated topoisomerase II inhibition and cleavage complex stabilization via enzyme relaxation assays.
Measured cellular uptake, macromolecular synthesis rates, and cell-cycle distribution in B16 melanoma cells using fluorescence microscopy and Feulgen image cytometry.
Cryptolepine intercalates tightly into DNA with a strong preference for GC-rich sequences over adenine-thymine homooligomers.
The alkaloid acts as a potent topoisomerase II inhibitor by stabilizing topoisomerase II-DNA cleavage complexes and stimulating DNA cleavage at specific sites.
Treated B16 melanoma cells selectively accumulate the compound in their nuclei, arrest in G2/M phases, and exhibit preferential inhibition of DNA synthesis over RNA and protein synthesis.

Cite This Study

Bonjean et al. (1998) studied this question.

synapsesocial.com/papers/69fcf82c9f13d6d4f45090c8 https://doi.org/10.1021/bi972927q

View Full Paper

Ask AI

Bookmark

Implication

In vitro study reveals cryptolepine intercalates DNA and blocks topoisomerase II in B16 melanoma cells, highlighting its promise for antitumor drug development.

The DNA Intercalating Alkaloid Cryptolepine Interferes with Topoisomerase II and Inhibits Primarily DNA Synthesis in B16 Melanoma Cells

Discussion

Member takes

Implication

Key Points

Cite This Study

The DNA Intercalating Alkaloid Cryptolepine Interferes with Topoisomerase II and Inhibits Primarily DNA Synthesis in B16 Melanoma Cells

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider